Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins-Reference-Cited by-同舟云学术

Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins

Published:2020-04-10 Issue:6 Volume:11 Page:1145-1151
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Yamaguchi-Sasaki Toru¹^ORCID,Tokura Seiken²,Ogata Yuya¹,Kawaguchi Takanori¹,Sugaya Yutaka³,Takahashi Ryo¹,Iwakiri Kanako¹,Abe-Kumasaka Tomoko³,Yoshida Ippei³,Arikawa Kaho³,Sugiyama Hiroyuki³,Kanuma Kosuke¹

Affiliation:

1. Medicinal Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan

2. Discovery Technologies Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan

3. Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00008

Reference42 articles.

1. Respiratory Syncytial Virus Bronchiolitis in Infancy Is an Important Risk Factor for Asthma and Allergy at Age 7

2. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life

3. Severe Respiratory Syncytial Virus Bronchiolitis in Infancy and Asthma and Allergy at Age 13

4. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

5. Impact of Wheezing After Respiratory Syncytial Virus Infection on Health-Related Quality of Life

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents;Journal of Medicinal Chemistry;2024-07-06

2. Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein;Signal Transduction and Targeted Therapy;2024-06-10

3. Macrocyclization strategy for improving candidate profiles in medicinal chemistry;European Journal of Medicinal Chemistry;2024-06

4. Pharmacological Potential of Pyrmidine Derivatives: A Review With Emphasis on Antiviral Effects and Virtual Screening Against Sars‐Cov‐2 Molecular Targets;ChemistrySelect;2023-06-13

5. An efficient microwave assisted copper catalyzed C-3 amination of 3-bromopyrazolo[1,5-a]pyrimidine;Tetrahedron Letters;2023-03